The pathogenesis of pre-eclampsia in kidney donors

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nature Reviews Nephrology

• Publication date

  2022-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41581-022-00646-0PMID 36303023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway

  2022cited by this paper
• Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance

  2022cited by this paper
• Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study

  2021cited by this paper
• The impact of chronic kidney disease Stages 3–5 on pregnancy outcomes

  2020cited by this paper
• A Systematic Review on Materno-Foetal Outcomes in Pregnant Women with IgA Nephropathy: A Case of “Late-Maternal” Preeclampsia?

  2018cited by this paper
• Living kidney donation: outcomes, ethics, and uncertainty.

  2015cited by this paper
• A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy.

  2015cited by this paper
• Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers.

  2013cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Harvesting-resistant estimates of air pollution effects on mortality.

  1999cited by this paper
• A woman's own birth weight and gestational age predict her later risk of developing preeclampsia, a precursor of chronic disease.

  1999cited by this paper

• No citing papers are available for this paper.